List of Tables
Table 1. ICU-acquired Acute Kidney Treatment Market Trends
Table 2. ICU-acquired Acute Kidney Treatment Market Drivers & Opportunity
Table 3. ICU-acquired Acute Kidney Treatment Market Challenges
Table 4. ICU-acquired Acute Kidney Treatment Market Restraints
Table 5. Global ICU-acquired Acute Kidney Treatment Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global ICU-acquired Acute Kidney Treatment Revenue Market Share by Company (2019-2024)
Table 7. Key Companies ICU-acquired Acute Kidney Treatment Manufacturing Base Distribution and Headquarters
Table 8. Key Companies ICU-acquired Acute Kidney Treatment Product Type
Table 9. Key Companies Time to Begin Mass Production of ICU-acquired Acute Kidney Treatment
Table 10. Global ICU-acquired Acute Kidney Treatment Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ICU-acquired Acute Kidney Treatment as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global ICU-acquired Acute Kidney Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global ICU-acquired Acute Kidney Treatment Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global ICU-acquired Acute Kidney Treatment Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global ICU-acquired Acute Kidney Treatment Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global ICU-acquired Acute Kidney Treatment Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global ICU-acquired Acute Kidney Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global ICU-acquired Acute Kidney Treatment Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global ICU-acquired Acute Kidney Treatment Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global ICU-acquired Acute Kidney Treatment Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global ICU-acquired Acute Kidney Treatment Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global ICU-acquired Acute Kidney Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global ICU-acquired Acute Kidney Treatment Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global ICU-acquired Acute Kidney Treatment Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global ICU-acquired Acute Kidney Treatment Sales Value by Region (2019-2024) & (%)
Table 27. Global ICU-acquired Acute Kidney Treatment Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions ICU-acquired Acute Kidney Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions ICU-acquired Acute Kidney Treatment Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions ICU-acquired Acute Kidney Treatment Sales Value, (2025-2030) & (US$ Million)
Table 31. Quark Pharmaceuticals Basic Information List
Table 32. Quark Pharmaceuticals Description and Business Overview
Table 33. Quark Pharmaceuticals ICU-acquired Acute Kidney Treatment Products, Services and Solutions
Table 34. Revenue (US$ Million) in ICU-acquired Acute Kidney Treatment Business of Quark Pharmaceuticals (2019-2024)
Table 35. Quark Pharmaceuticals Recent Developments
Table 36. Fresenius Medical Care Basic Information List
Table 37. Fresenius Medical Care Description and Business Overview
Table 38. Fresenius Medical Care ICU-acquired Acute Kidney Treatment Products, Services and Solutions
Table 39. Revenue (US$ Million) in ICU-acquired Acute Kidney Treatment Business of Fresenius Medical Care (2019-2024)
Table 40. Fresenius Medical Care Recent Developments
Table 41. B. Braun Basic Information List
Table 42. B. Braun Description and Business Overview
Table 43. B. Braun ICU-acquired Acute Kidney Treatment Products, Services and Solutions
Table 44. Revenue (US$ Million) in ICU-acquired Acute Kidney Treatment Business of B. Braun (2019-2024)
Table 45. B. Braun Recent Developments
Table 46. Baxter international Basic Information List
Table 47. Baxter international Description and Business Overview
Table 48. Baxter international ICU-acquired Acute Kidney Treatment Products, Services and Solutions
Table 49. Revenue (US$ Million) in ICU-acquired Acute Kidney Treatment Business of Baxter international (2019-2024)
Table 50. Baxter international Recent Developments
Table 51. Angion Biomedica Corp Basic Information List
Table 52. Angion Biomedica Corp Description and Business Overview
Table 53. Angion Biomedica Corp ICU-acquired Acute Kidney Treatment Products, Services and Solutions
Table 54. Revenue (US$ Million) in ICU-acquired Acute Kidney Treatment Business of Angion Biomedica Corp (2019-2024)
Table 55. Angion Biomedica Corp Recent Developments
Table 56. Asahi Kasei Medical Basic Information List
Table 57. Asahi Kasei Medical Description and Business Overview
Table 58. Asahi Kasei Medical ICU-acquired Acute Kidney Treatment Products, Services and Solutions
Table 59. Revenue (US$ Million) in ICU-acquired Acute Kidney Treatment Business of Asahi Kasei Medical (2019-2024)
Table 60. Asahi Kasei Medical Recent Developments
Table 61. Key Raw Materials Lists
Table 62. Raw Materials Key Suppliers Lists
Table 63. ICU-acquired Acute Kidney Treatment Downstream Customers
Table 64. ICU-acquired Acute Kidney Treatment Distributors List
Table 65. Research Programs/Design for This Report
Table 66. Key Data Information from Secondary Sources
Table 67. Key Data Information from Primary Sources
Table 68. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. ICU-acquired Acute Kidney Treatment Product Picture
Figure 2. Global ICU-acquired Acute Kidney Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global ICU-acquired Acute Kidney Treatment Sales Value (2019-2030) & (US$ Million)
Figure 4. ICU-acquired Acute Kidney Treatment Report Years Considered
Figure 5. Global ICU-acquired Acute Kidney Treatment Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by ICU-acquired Acute Kidney Treatment Revenue in 2023
Figure 7. ICU-acquired Acute Kidney Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Pre-renal Picture
Figure 9. Intrinsic-renal Picture
Figure 10. Post-renal Picture
Figure 11. Global ICU-acquired Acute Kidney Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global ICU-acquired Acute Kidney Treatment Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Public Hospital
Figure 14. Product Picture of Private Hospital
Figure 15. Global ICU-acquired Acute Kidney Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global ICU-acquired Acute Kidney Treatment Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America ICU-acquired Acute Kidney Treatment Sales Value (2019-2030) & (US$ Million)
Figure 18. North America ICU-acquired Acute Kidney Treatment Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe ICU-acquired Acute Kidney Treatment Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe ICU-acquired Acute Kidney Treatment Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific ICU-acquired Acute Kidney Treatment Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific ICU-acquired Acute Kidney Treatment Sales Value by Country (%), 2023 VS 2030
Figure 23. South America ICU-acquired Acute Kidney Treatment Sales Value (2019-2030) & (US$ Million)
Figure 24. South America ICU-acquired Acute Kidney Treatment Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa ICU-acquired Acute Kidney Treatment Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa ICU-acquired Acute Kidney Treatment Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions ICU-acquired Acute Kidney Treatment Sales Value (%), (2019-2030)
Figure 28. United States ICU-acquired Acute Kidney Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States ICU-acquired Acute Kidney Treatment Sales Value by Type (%), 2023 VS 2030
Figure 30. United States ICU-acquired Acute Kidney Treatment Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe ICU-acquired Acute Kidney Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe ICU-acquired Acute Kidney Treatment Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe ICU-acquired Acute Kidney Treatment Sales Value by Application (%), 2023 VS 2030
Figure 34. China ICU-acquired Acute Kidney Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 35. China ICU-acquired Acute Kidney Treatment Sales Value by Type (%), 2023 VS 2030
Figure 36. China ICU-acquired Acute Kidney Treatment Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan ICU-acquired Acute Kidney Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan ICU-acquired Acute Kidney Treatment Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan ICU-acquired Acute Kidney Treatment Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea ICU-acquired Acute Kidney Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea ICU-acquired Acute Kidney Treatment Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea ICU-acquired Acute Kidney Treatment Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia ICU-acquired Acute Kidney Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia ICU-acquired Acute Kidney Treatment Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia ICU-acquired Acute Kidney Treatment Sales Value by Application (%), 2023 VS 2030
Figure 46. India ICU-acquired Acute Kidney Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 47. India ICU-acquired Acute Kidney Treatment Sales Value by Type (%), 2023 VS 2030
Figure 48. India ICU-acquired Acute Kidney Treatment Sales Value by Application (%), 2023 VS 2030
Figure 49. ICU-acquired Acute Kidney Treatment Industrial Chain
Figure 50. ICU-acquired Acute Kidney Treatment Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
